Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Taysha Gene Therapies (TSHA) Asset Utilization Ratio (2022 - 2025)

Taysha Gene Therapies' Asset Utilization Ratio history spans 4 years, with the latest figure at 0.02 for Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 62.73% year-over-year to 0.02; the TTM value through Sep 2025 reached 0.02, down 62.73%, while the annual FY2024 figure was 0.05, 51.59% down from the prior year.
  • Asset Utilization Ratio for Q3 2025 was 0.02 at Taysha Gene Therapies, down from 0.03 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.09 in Q1 2024 and bottomed at 0.04 in Q4 2022.
  • The 4-year median for Asset Utilization Ratio is 0.05 (2024), against an average of 0.04.
  • The largest annual shift saw Asset Utilization Ratio surged 5528.88% in 2024 before it crashed 62.73% in 2025.
  • A 4-year view of Asset Utilization Ratio shows it stood at 0.04 in 2022, then skyrocketed by 291.69% to 0.08 in 2023, then tumbled by 41.67% to 0.05 in 2024, then plummeted by 60.32% to 0.02 in 2025.
  • Per Business Quant, the three most recent readings for TSHA's Asset Utilization Ratio are 0.02 (Q3 2025), 0.03 (Q2 2025), and 0.05 (Q1 2025).